Beneficial effects of trimetazidine (Vastarel®MR) in patients with chronic heart failure
- Author
- FRAGASSO, Gabriele1 ; ALBERTI, Luca1 ; LAURETTA, Ludovica1
[1] Division of Metabolic and Cardiovascular Sciences, Istituto Scientifico H San Raffaele, Milano, Italy - Issue title
- Energetics in heart disease
- Author (monograph)
- FEUVRAY, Danielle (Author of introductory parts)1
[1] UPS & CNRS UMR 8162, Marie Lannelongue Hospital, 92350 Le Plessis Robinson, France - Source
Heart and metabolism. 2011, Num 53, pp 25-28, 4 p ; ref : 36 ref
- ISSN
- 1566-0338
- Scientific domain
- Cardiology, blood circulation, phlebology
- Publisher
- Servier, Neuilly sur Seine
- Publication country
- France
- Document type
- Article
- Language
- English
- Author keyword
- energy expenditure left ventricular function metabolic therapy systolic-dysfunction heart failure
- Keyword (fr)
- Cardiologie Chronique Dépense énergétique Fonction ventriculaire gauche Homme Insuffisance cardiaque Malade Traitement Trimétazidine Trouble fonctionnel Cardiopathie Pathologie de l'appareil circulatoire
- Keyword (en)
- Cardiology Chronic Energetic cost Left ventricle performance Human Heart failure Patient Treatment Trimetazidine Dysfunction Heart disease Cardiovascular disease
- Keyword (es)
- Cardiología Crónico Costo energético Función ventricular izquierda Hombre Insuficiencia cardíaca Enfermo Tratamiento Trimetazidina Trastorno funcional Cardiopatía Aparato circulatorio patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12A Heart / 002B12A01 Heart failure, cardiogenic pulmonary edema, cardiac enlargement
- Discipline
- Cardiology. Circulatory system
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 25868407
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"Beneficial effects of trimetazidine (Vastarel\u00aeMR) in patients with chronic heart failure\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Heart and metabolism\";s:9:\"\u0000*\u0000stitle\";s:11:\"Heart metab\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:0:\"\";s:8:\"\u0000*\u0000issue\";s:2:\"53\";s:8:\"\u0000*\u0000spage\";s:2:\"25\";s:8:\"\u0000*\u0000epage\";s:2:\"28\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1566-0338\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"FRAGASSO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Gabriele\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:13:\"ALBERTI, Luca\";i:1;s:18:\"LAURETTA, Ludovica\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:27:\"Energetics in heart disease\";s:8:\"\u0000*\u0000title\";s:89:\"Beneficial effects of trimetazidine (Vastarel\u00aeMR) in patients with chronic heart failure\";s:8:\"\u0000*\u0000place\";s:17:\"Neuilly sur Seine\";s:6:\"\u0000*\u0000pub\";s:7:\"Servier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"Beneficial effects of trimetazidine (Vastarel\u00aeMR) in patients with chronic heart failure\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Heart and metabolism\";s:9:\"\u0000*\u0000stitle\";s:11:\"Heart metab\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:0:\"\";s:8:\"\u0000*\u0000issue\";s:2:\"53\";s:8:\"\u0000*\u0000spage\";s:2:\"25\";s:8:\"\u0000*\u0000epage\";s:2:\"28\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1566-0338\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"FRAGASSO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Gabriele\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:13:\"ALBERTI, Luca\";i:1;s:18:\"LAURETTA, Ludovica\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:27:\"Energetics in heart disease\";s:8:\"\u0000*\u0000title\";s:89:\"Beneficial effects of trimetazidine (Vastarel\u00aeMR) in patients with chronic heart failure\";s:8:\"\u0000*\u0000place\";s:17:\"Neuilly sur Seine\";s:6:\"\u0000*\u0000pub\";s:7:\"Servier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"Beneficial effects of trimetazidine (Vastarel\u00aeMR) in patients with chronic heart failure\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Heart and metabolism\";s:9:\"\u0000*\u0000stitle\";s:11:\"Heart metab\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:0:\"\";s:8:\"\u0000*\u0000issue\";s:2:\"53\";s:8:\"\u0000*\u0000spage\";s:2:\"25\";s:8:\"\u0000*\u0000epage\";s:2:\"28\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1566-0338\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"FRAGASSO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Gabriele\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:13:\"ALBERTI, Luca\";i:1;s:18:\"LAURETTA, Ludovica\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:27:\"Energetics in heart disease\";s:8:\"\u0000*\u0000title\";s:89:\"Beneficial effects of trimetazidine (Vastarel\u00aeMR) in patients with chronic heart failure\";s:8:\"\u0000*\u0000place\";s:17:\"Neuilly sur Seine\";s:6:\"\u0000*\u0000pub\";s:7:\"Servier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"Beneficial effects of trimetazidine (Vastarel\u00aeMR) in patients with chronic heart failure\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Heart and metabolism\";s:9:\"\u0000*\u0000stitle\";s:11:\"Heart metab\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:0:\"\";s:8:\"\u0000*\u0000issue\";s:2:\"53\";s:8:\"\u0000*\u0000spage\";s:2:\"25\";s:8:\"\u0000*\u0000epage\";s:2:\"28\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1566-0338\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"FRAGASSO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Gabriele\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:13:\"ALBERTI, Luca\";i:1;s:18:\"LAURETTA, Ludovica\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:27:\"Energetics in heart disease\";s:8:\"\u0000*\u0000title\";s:89:\"Beneficial effects of trimetazidine (Vastarel\u00aeMR) in patients with chronic heart failure\";s:8:\"\u0000*\u0000place\";s:17:\"Neuilly sur Seine\";s:6:\"\u0000*\u0000pub\";s:7:\"Servier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"Beneficial effects of trimetazidine (Vastarel\u00aeMR) in patients with chronic heart failure\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Heart and metabolism\";s:9:\"\u0000*\u0000stitle\";s:11:\"Heart metab\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:0:\"\";s:8:\"\u0000*\u0000issue\";s:2:\"53\";s:8:\"\u0000*\u0000spage\";s:2:\"25\";s:8:\"\u0000*\u0000epage\";s:2:\"28\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1566-0338\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"FRAGASSO\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Gabriele\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:2:{i:0;s:13:\"ALBERTI, Luca\";i:1;s:18:\"LAURETTA, Ludovica\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:27:\"Energetics in heart disease\";s:8:\"\u0000*\u0000title\";s:89:\"Beneficial effects of trimetazidine (Vastarel\u00aeMR) in patients with chronic heart failure\";s:8:\"\u0000*\u0000place\";s:17:\"Neuilly sur Seine\";s:6:\"\u0000*\u0000pub\";s:7:\"Servier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
